Literature DB >> 34819668

ecDNA hubs drive cooperative intermolecular oncogene expression.

King L Hung1, Kathryn E Yost1, Liangqi Xie2,3,4, Quanming Shi1, Konstantin Helmsauer5, Jens Luebeck6,7, Robert Schöpflin8,9,10, Joshua T Lange11,12,13, Rocío Chamorro González5, Natasha E Weiser1,13, Celine Chen5, Maria E Valieva8,9, Ivy Tsz-Lo Wong12,13, Sihan Wu14, Siavash R Dehkordi7, Connor V Duffy1, Katerina Kraft1, Jun Tang12,13, Julia A Belk13,15, John C Rose1, M Ryan Corces1, Jeffrey M Granja1, Rui Li1, Utkrisht Rajkumar7, Jordan Friedlein16, Anindya Bagchi16, Ansuman T Satpathy13, Robert Tjian3,4, Stefan Mundlos8,9,17, Vineet Bafna7, Anton G Henssen5,18,19,20, Paul S Mischel12,13, Zhe Liu2, Howard Y Chang21,22.   

Abstract

Extrachromosomal DNA (ecDNA) is prevalent in human cancers and mediates high expression of oncogenes through gene amplification and altered gene regulation1. Gene induction typically involves cis-regulatory elements that contact and activate genes on the same chromosome2,3. Here we show that ecDNA hubs-clusters of around 10-100 ecDNAs within the nucleus-enable intermolecular enhancer-gene interactions to promote oncogene overexpression. ecDNAs that encode multiple distinct oncogenes form hubs in diverse cancer cell types and primary tumours. Each ecDNA is more likely to transcribe the oncogene when spatially clustered with additional ecDNAs. ecDNA hubs are tethered by the bromodomain and extraterminal domain (BET) protein BRD4 in a MYC-amplified colorectal cancer cell line. The BET inhibitor JQ1 disperses ecDNA hubs and preferentially inhibits ecDNA-derived-oncogene transcription. The BRD4-bound PVT1 promoter is ectopically fused to MYC and duplicated in ecDNA, receiving promiscuous enhancer input to drive potent expression of MYC. Furthermore, the PVT1 promoter on an exogenous episome suffices to mediate gene activation in trans by ecDNA hubs in a JQ1-sensitive manner. Systematic silencing of ecDNA enhancers by CRISPR interference reveals intermolecular enhancer-gene activation among multiple oncogene loci that are amplified on distinct ecDNAs. Thus, protein-tethered ecDNA hubs enable intermolecular transcriptional regulation and may serve as units of oncogene function and cooperative evolution and as potential targets for cancer therapy.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34819668      PMCID: PMC9126690          DOI: 10.1038/s41586-021-04116-8

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  76 in total

1.  Loss of irreversibility of granulocytic differentiation induced by dimethyl sulfoxide in HL-60 sublines with a homogeneously staining region.

Authors:  K Kitajima; M Haque; H Nakamura; T Hirano; H Utiyama
Journal:  Biochem Biophys Res Commun       Date:  2001-11-16       Impact factor: 3.575

2.  Double minute chromosomes can be produced from precursors derived from a chromosomal deletion.

Authors:  S M Carroll; M L DeRose; P Gaudray; C M Moore; D R Needham-Vandevanter; D D Von Hoff; G M Wahl
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

3.  Double-strand breakage in the extrachromosomal double minutes triggers their aggregation in the nucleus, micronucleation, and morphological transformation.

Authors:  Yoshihiro Oobatake; Noriaki Shimizu
Journal:  Genes Chromosomes Cancer       Date:  2019-10-04       Impact factor: 5.006

4.  Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells.

Authors:  T Kanda; K F Sullivan; G M Wahl
Journal:  Curr Biol       Date:  1998-03-26       Impact factor: 10.834

5.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

6.  OneD: increasing reproducibility of Hi-C samples with abnormal karyotypes.

Authors:  Enrique Vidal; François le Dily; Javier Quilez; Ralph Stadhouders; Yasmina Cuartero; Thomas Graf; Marc A Marti-Renom; Miguel Beato; Guillaume J Filion
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

7.  A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.

Authors:  Jihyun Park; Sun Young Kim; Ha-Jung Kim; Kyoung-Mee Kim; Eun Young Choi; Myung-Soo Kang
Journal:  Oncotarget       Date:  2016-05-10

8.  Exploring the landscape of focal amplifications in cancer using AmpliconArchitect.

Authors:  Viraj Deshpande; Jens Luebeck; Nam-Phuong D Nguyen; Mehrdad Bakhtiari; Kristen M Turner; Richard Schwab; Hannah Carter; Paul S Mischel; Vineet Bafna
Journal:  Nat Commun       Date:  2019-01-23       Impact factor: 17.694

9.  Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs.

Authors:  Kevin Hadi; Xiaotong Yao; Julie M Behr; Aditya Deshpande; Charalampos Xanthopoulakis; Huasong Tian; Sarah Kudman; Joel Rosiene; Madison Darmofal; Joseph DeRose; Rick Mortensen; Emily M Adney; Alon Shaiber; Zoran Gajic; Michael Sigouros; Kenneth Eng; Jeremiah A Wala; Kazimierz O Wrzeszczyński; Kanika Arora; Minita Shah; Anne-Katrin Emde; Vanessa Felice; Mayu O Frank; Robert B Darnell; Mahmoud Ghandi; Franklin Huang; Sally Dewhurst; John Maciejowski; Titia de Lange; Jeremy Setton; Nadeem Riaz; Jorge S Reis-Filho; Simon Powell; David A Knowles; Ed Reznik; Bud Mishra; Rameen Beroukhim; Michael C Zody; Nicolas Robine; Kenji M Oman; Carissa A Sanchez; Mary K Kuhner; Lucian P Smith; Patricia C Galipeau; Thomas G Paulson; Brian J Reid; Xiaohong Li; David Wilkes; Andrea Sboner; Juan Miguel Mosquera; Olivier Elemento; Marcin Imielinski
Journal:  Cell       Date:  2020-10-01       Impact factor: 66.850

10.  Tn5 transposase and tagmentation procedures for massively scaled sequencing projects.

Authors:  Simone Picelli; Asa K Björklund; Björn Reinius; Sven Sagasser; Gösta Winberg; Rickard Sandberg
Journal:  Genome Res       Date:  2014-07-30       Impact factor: 9.043

View more
  20 in total

Review 1.  Guilt by association: EcDNA as a mobile transactivator in cancer.

Authors:  Yanfen Zhu; Liang Gong; Chia-Lin Wei
Journal:  Trends Cancer       Date:  2022-06-23

Review 2.  Gene regulation on extrachromosomal DNA.

Authors:  King L Hung; Paul S Mischel; Howard Y Chang
Journal:  Nat Struct Mol Biol       Date:  2022-08-10       Impact factor: 18.361

3.  Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Authors:  Daniel Zingg; Jinhyuk Bhin; Julia Yemelyanenko; Sjors M Kas; Frank Rolfs; Catrin Lutz; Jessica K Lee; Sjoerd Klarenbeek; Ian M Silverman; Stefano Annunziato; Chang S Chan; Sander R Piersma; Timo Eijkman; Madelon Badoux; Ewa Gogola; Bjørn Siteur; Justin Sprengers; Bim de Klein; Richard R de Goeij-de Haas; Gregory M Riedlinger; Hua Ke; Russell Madison; Anne Paulien Drenth; Eline van der Burg; Eva Schut; Linda Henneman; Martine H van Miltenburg; Natalie Proost; Huiling Zhen; Ellen Wientjens; Roebi de Bruijn; Julian R de Ruiter; Ute Boon; Renske de Korte-Grimmerink; Bastiaan van Gerwen; Luis Féliz; Ghassan K Abou-Alfa; Jeffrey S Ross; Marieke van de Ven; Sven Rottenberg; Edwin Cuppen; Anne Vaslin Chessex; Siraj M Ali; Timothy C Burn; Connie R Jimenez; Shridar Ganesan; Lodewyk F A Wessels; Jos Jonkers
Journal:  Nature       Date:  2022-08-10       Impact factor: 69.504

Review 4.  Structural variations in cancer and the 3D genome.

Authors:  Frank Dubois; Nikos Sidiropoulos; Joachim Weischenfeldt; Rameen Beroukhim
Journal:  Nat Rev Cancer       Date:  2022-06-28       Impact factor: 69.800

Review 5.  Extrachromosomal DNA amplifications in cancer.

Authors:  Eunhee Yi; Rocío Chamorro González; Anton G Henssen; Roel G W Verhaak
Journal:  Nat Rev Genet       Date:  2022-08-11       Impact factor: 59.581

Review 6.  Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Authors:  Imran Noorani; Paul S Mischel; Charles Swanton
Journal:  Nat Rev Clin Oncol       Date:  2022-09-21       Impact factor: 65.011

Review 7.  Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.

Authors:  Seng Chuan Tang; Udhaya Vijayakumar; Ying Zhang; Melissa Jane Fullwood
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 8.  Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.

Authors:  Zesheng Li; Bo Wang; Hao Liang; Lei Han
Journal:  Int J Biol Sci       Date:  2022-06-13       Impact factor: 10.750

Review 9.  The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.

Authors:  Eric van Leen; Lotte Brückner; Anton G Henssen
Journal:  Nat Genet       Date:  2022-02-10       Impact factor: 41.307

10.  Live-Cell Imaging Shows Uneven Segregation of Extrachromosomal DNA Elements and Transcriptionally Active Extrachromosomal DNA Hubs in Cancer.

Authors:  Eunhee Yi; Amit D Gujar; Molly Guthrie; Hoon Kim; Dacheng Zhao; Kevin C Johnson; Samirkumar B Amin; Megan L Costa; Qianru Yu; Sunit Das; Nathaniel Jillette; Patricia A Clow; Albert W Cheng; Roel G W Verhaak
Journal:  Cancer Discov       Date:  2021-11-24       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.